Thermo Fisher Scientific Inc.
TMONYSEMeasuring & Controlling Devices, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 26, 2026Last filing: 10-Q on Oct 30, 2026Score 12/3025% above fair value
$682.65−14.35 (-2.06%)
Close on Nov 2, 2026Market cap $252.41BP/E 36.0Yield 0.25%
Thermo Fisher Scientific Net Debt / TTM EBITDA: 2.80× in FY2025, up 12.0% from a year earlier.
Latest, FY2025
2.80
Period ended Dec 31, 2025
Change on a year earlier
+12.0%
2.50 in FY2024
History
5 years
Since FY2021
Sources
3
Documents cited below
Where the FY2025 figure comes from
“Net debt / TTM EBITDA 2.6 X 2.5 X 2.8 X 3.7 X 3.5 X 3.1 X”
Source: Q3 2026 Reconciliation of Financial Information ↗
Reported in IR Financial Reconciliation Package (Page 12 Leverage Ratios).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Net Debt / TTM EBITDA (×) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 2.80 | +12.0% | Q3 2026 Reconciliation of Financial Information ↗ |
| FY2024 | Dec 31, 2024 | 2.50 | -3.8% | Q3 2026 Reconciliation of Financial Information ↗ |
| FY2023 | Dec 31, 2023 | 2.60 | +18.2% | Q3 2026 Reconciliation of Financial Information ↗ |
| FY2022 | Dec 31, 2022 | 2.20 | -8.3% | Q4 & FY2025 Reconciliation of Financial Information ↗ |
| FY2021 | Dec 31, 2021 | 2.40 | – | Q4 & FY2024 Reconciliation of Financial Information ↗ |
Cite this data
StockData. (2026). Thermo Fisher Scientific Net Debt / TTM EBITDA (×), annual FY2021–FY2025 [Data set]. Compiled from Thermo Fisher Scientific SEC filings and investor materials. https://stockdatahq.com/stocks/tmo/kpis/lev-net-debt-ebitda-x
See every metric in the Thermo Fisher Scientific KPI table. Data updated Oct 29, 2026.